:::

詳目顯示

回上一頁
題名:The Herbal Preparation Wu-chu-yu-tang Enhances the Excretion of the CYP1A2 Substrate Caffeine in Mice
書刊名:中醫藥雜誌
作者:翁芸芳王姝勻
作者(外文):Ueng, Yune-fangWang, Shu-yun
出版日期:2003
卷期:14:3
頁次:頁175-181
主題關鍵詞:吳茱萸湯咖啡因交互作用Wu-chu-yu-tangCYP1A2Caffeine
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:0
期刊論文
1.Lowry, O. H.、Rosebrough, N. J.、Farr, A. L.、Randall, R. J.(1951)。Protein measurement with the Folin phenol reagent。Journal Biological Chemistry,193(1),265-275。  new window
2.Alvares, A. P.、Mannering, G. J.(1970)。Two substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes。Mol. Pharmacol.,6,206-212。  new window
3.Omura, T.、Sato, R.(1964)。The carbon monoxide‑binding pigment of liver microsomes: I--Evidence for its hemeprotein nature。J. Biol. Chem.,239,2370‑2379。  new window
4.Pohl, R. J.、Fouts, J. R.(1980)。A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions。Anal. Biochem.,107,150-155。  new window
5.Guengerich, F. P.(1997)。Roles of cytochrome P450 enzymes in drug-drug interactions。Adv. Pharmacology,43,7-35。  new window
6.Kano, Y.、Zong, Q.、Komatsu, K.(1991)。Pharmacological properties of Galenical preparation. XIV. Body temperature retaining effect of the Chinese traditional medicine, "Goshuyu-to" and component crude drugs。Chem. Pharm. Bull. (Tokyo),39,690-692。  new window
7.Ueng, Y. F.、Don, M. J.、Peng, H. C.、Wang, S. Y.、Wang, J. J.、Chen, C. F.(2002)。Effects of Wu-chu-yu-tang and its component herbs on drug-metabolizing enzymes。Jpn. J. Pharmacol.,89,267-273。  new window
8.Lee, H. S.、Jin, C.、Park, J.、Kim, D. H.(1994)。Modulation of cytochrome P450 activities by 7, 8-benzoflavone and its metabolites。Biochem. Mol. Biology Intl.,34,483-491。  new window
9.Buters, J. T. M.、Tang, B. K.、Pineau, T.、Gelboin, H. V.、Kimura, S.、Gonzalez, F. J.(1996)。Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2。Pharmacogenetics,6,291-296。  new window
10.Morey, S. S.(2000)。Guidelines on migraine: part 3. recommendations for individual drugs。Amer. Family Physicians,62,2145-2151。  new window
11.Morey, S. S.(2000)。Guidelines on migraine: part 2. general principles of drug therapy。Amer. Family Physicians,62,1915-1917。  new window
12.Nyéki, Á.、Biollaz, J.、Kesselring, U. W.、Décosterd, L. A.(2001)。Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment。J. Chromatogr. B,755,73-84。  new window
13.Kalow, W.、Tang, B. K.(1993)。The use of caffeine for enzyme assays: a critical appraisal。Clin. Pharmacol. Ther.,53,503-514。  new window
14.Blanchard, J.、Sawers, S. J. A.(1982)。The absolute bioavailability of caffeine in man。Eur. J. Clin. Pharmacol.,32,98-106。  new window
圖書論文
1.Guengerich, F. P.(1995)。Human cytochrome P450 enzymes。Cytochrome P450。Plenum Press。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
無相關點閱
 
QR Code
QRCODE